Phase I/IIa trial in advanced pancreatic ductal adenocarcinoma treated with cytotoxic drug-packaged, EGFR-targeted nanocells and glycolipid-packaged nanocells

Written By PASO Medical

Date: 29 November 2023

https://aacrjournals.org/clincancerres/article-abstract/doi/10.1158/1078-0432.CCR-23-1821/730179/Phase-I-IIa-trial-in-advanced-pancreatic-ductal?redirectedFrom=fulltext

PASO Medical https://paso.com.au
Previous

Genentech Announces Positive Phase III Results for Inavolisib Combination in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Next

PASO Joins ClinTrial Refer